Analyst initiations: EFII, FNDT and VIAP
Posted Nov 27th 2007 11:01AM by Eric Buscemi
Filed under: Analyst initiations
.gif)
MOST NOTEWORTHY: Electronics for Imaging, Fundtech and VIA Pharmaceuticals were today's noteworthy initiations:
- Banc of America initiated Electronics for Imaging (NASDAQ: EFII) with a Buy rating and $26.50 target, as it sees leverage potential in 2008 from cost reductions and revenue mix and believes stronger controller revenue mix and ink from inkjets could help gross margin in 2H08.
- JMP Securities expects Fundtech (NASDAQ: FNDT) to benefit from an upgrade cycle among large banks to improve their payment systems, starting shares off with a Market Outperform rating and $19 target.
- Rodman & Renshaw resumed coverage of VIA Pharmaceuticals (NASDAQ: VIAP) with an Outperform rating and $4 target. The firm expects VIAP's VIA-2291, a treatment for Antherosclerosis, Ph II data expected in mid-2008 to drive shares.
OTHER INITIATIONS:
Tags: Analyst Initiations, AnalystInitiations, Ardea Biosciences, ArdeaBiosciences, EFII, Electronics for Imaging, ElectronicsForImaging, FNDT, Fundtech, Limelight Networks, LimelightNetworks, LLNW, RDEA, SAP, SAP AG, SapAg, VIA Pharmaceuticals, VIAP, ViaPharmaceuticals
The week in preview: No turkey earnings from Tyson, Hormel, Cracker Barrel ...
Comfort Zone Investing: Intel is saying something ... can you hear it?
Twitter finally reveals revenue ambition, wants to be Google -- but not yet
